The isolation of a diverse sample of circulating tumor cells (CTCs) can be achieved either in an active or passive manner. While passive approaches manage cells via channel architectures, intrinsic hydrodynamic forces, and steric hindrances, active methods use external fields like electric, magnetic, acoustic, and optical forces to separate cells. However, processing complex biological materials, such as whole blood with unusual cells, makes separation with a single-module microfluidic device difficult. In recent years, hybrid microfluidic devices with both passive and active components have gained popularity as a method for the label-free enrichment of circulating tumor cells due to their many advantages, such as high sensitivity, high efficiency, and multi-target cell processing. The goal of this study was to create a near-infrared (NIR) light-responsive substrate by combining a thermos-responsive film with microchannels of varying lengths in order to accomplish an extremely efficient targeted capture and biocompatible site-release of CTCs. Pre-synthesized photothermal agent gold nanorods (GNRs) were integrated into biodegradable scaffolds. Later, a nano-film was fixed onto a chip. To improve the capture efficiency of receptors, molecule folic acid (FA) and haluronic acid (HA) targeting cancer cells were respectively adsorbed using a straightforward dipping technique for a GNR film. Temperature-responsive films quickly change their conformation upon NIR irradiation at 37°C or higher, enabling either site-specific release of individual CTCs through NIR-mediated photothermal activation of embedded GNRs, or the bulk recovery of trapped CTCs at a physiological temperature. This hybrid microfluidic NIR-responsive platform not only provides a robust and flexible route toward tailored anticancer therapies, but it also excels in the collection and site-release of CTCs with excellent survivability.